Keith Katkin, President and CEO at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 105,906 shares at $3.31 ($334K) on 2010-04-30, disclosed to the SEC on 2010-05-04.
Scheduled sale ($334k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.31 | 40,000 | $132K | 39.6% |
| 2 | $3.06 | 65,906 | $202K | 60.4% |
| Total | $3.15 avg | 105,906 | $334K | 100% |
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |